#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3824694	Toxicity	Toxicity in po dosed Sprague-Dawley rat assessed as motor impairment by inverted screen test	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
2.	ALA3825093	Binding	Antagonist activity at human iGluA1 receptor flop isoform expressed in CHO-S cells coexpressing TARP gamma-8 and human EAAT3 assessed as inhibition of glutamate-induced increase in intracellular calcium levels after 2 mins followed by cyclothiazide/glutamate addition by fluo-4 AM dye based fluorescence imaging plate reader method	Homo sapiens	16	ALA3822422	cell-based format	Scientific Literature
3.	ALA3825094	Binding	Antagonist activity at human iGluA1 receptor flop isoform expressed in CHO-S cells coexpressing TARP gamma-2 assessed as inhibition of glutamate-induced increase in intracellular calcium levels after 2 mins followed by cyclothiazide/glutamate addition by fluo-4 AM dye based fluorescence imaging plate reader method	Homo sapiens	15	ALA3822422	cell-based format	Scientific Literature
4.	ALA3825097	Binding	Antagonist activity at human iGluA1 receptor flip isoform expressed in CHO-S cells assessed as inhibition of glutamate-induced increase in intracellular calcium levels after 2 mins followed by cyclothiazide/glutamate addition by fluo-4 NW dye based fluorescence imaging plate reader method	Homo sapiens	15	ALA3822422	cell-based format	Scientific Literature
5.	ALA3825098	ADME	AUC in rat at 1 mg/kg, iv	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
6.	ALA3825099	ADME	Drug metabolism in human liver microsomes assessed as oxidative metabolite formation	Homo sapiens	14	ALA3822422	tissue-based format	Scientific Literature
7.	ALA3825100	ADME	Drug metabolism in rat liver microsomes assessed as oxidative metabolite formation	Rattus norvegicus	14	ALA3822422	tissue-based format	Scientific Literature
8.	ALA3825105	ADME	Clearance in rat	Rattus norvegicus	14	ALA3822422	organism-based format	Scientific Literature
9.	ALA3825110	ADME	Inhibition of human CYP1A2	Homo sapiens	9	ALA3822422	single protein format	Scientific Literature
10.	ALA3825278	Functional	Anticonvulsant activity in po dosed Sprague-Dawley rat assessed as inhibition of pentylenetetrazole-induced clonic convulsions administered 30 mins prior to PTZ dosing measured over 30 mins	Rattus norvegicus	2	ALA3822422	organism-based format	Scientific Literature
11.	ALA3825280	ADME	Oral bioavailability in rat at 3 mg/kg	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
12.	ALA3825284	ADME	Volume of distribution at steady state in rat at 1 mg/kg, iv	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
13.	ALA3825285	ADME	Clearance in rat at 1 mg/kg, iv	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
14.	ALA3825286	ADME	AUC in rat at 3 mg/kg, po	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
15.	ALA3825287	ADME	Tmax in rat at 3 mg/kg, po	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
16.	ALA3825288	ADME	Cmax in rat at 3 mg/kg, po	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
17.	ALA3825289	Functional	Potency index, ratio of perampanel ED50 to compound ED50 for inhibition of pentylenetetrazole-induced clonic convulsions in Sprague-Dawley rat	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
18.	ALA3825290	Functional	Anticonvulsant activity in po dosed Sprague-Dawley rat assessed as inhibition of pentylenetetrazole-induced clonic convulsions at 1 mg/kg administered 30 mins prior to PTZ dosing measured over 30 mins	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
19.	ALA3825291	Functional	Anticonvulsant activity in po dosed Sprague-Dawley rat assessed as inhibition of pentylenetetrazole-induced clonic convulsions at 3 mg/kg administered 30 mins prior to PTZ dosing measured over 30 mins	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature
20.	ALA3825292	Functional	Anticonvulsant activity in po dosed Sprague-Dawley rat assessed as inhibition of pentylenetetrazole-induced clonic convulsions at 10 mg/kg administered 30 mins prior to PTZ dosing measured over 30 mins	Rattus norvegicus	1	ALA3822422	organism-based format	Scientific Literature